| Literature DB >> 31129064 |
Robert J Hamilton1, Michael A S Jewett2, Padraig Warde3, Aaron Hansen4.
Abstract
At Princess Margaret, we recommend active surveillance for all patients with clinical stage I nonseminomatous germ cell tumor. Here we refute common arguments against surveillance and urge clinicians to engage in a shared decision-making process that goes beyond merely citing relapse rates for the different options.Entities:
Year: 2019 PMID： 31129064 DOI： 10.1016/j.euf.2019.05.003
Source DB: PubMed Journal: Eur Urol Focus ISSN： 2405-4569